131 related articles for article (PubMed ID: 37936585)
1. The diagnostic value of fluorescence
Chen B; Shu B; Liu Z; Zhu J; Ke C; Zeng X; Hu Z; Yang C
Bladder (San Franc); 2023; 10():e21200006. PubMed ID: 37936585
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine.
Ishiwata S; Takahashi S; Homma Y; Tanaka Y; Kameyama S; Hosaka Y; Kitamura T
Urology; 2001 Apr; 57(4):811-5. PubMed ID: 11306420
[TBL] [Abstract][Full Text] [Related]
3. Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients.
Nagai T; Okamura T; Yanase T; Chaya R; Moritoki Y; Kobayashi D; Akita H; Yasui T
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1271-1273. PubMed ID: 31030505
[TBL] [Abstract][Full Text] [Related]
4. The utility of fluorescence in situ hybridization for diagnosis and surveillance of bladder urothelial carcinoma.
Huang JW; Mu JG; Li YW; Gan XG; Song LJ; Gu BJ; Fu Q; Xu YM; An RH
Urol J; 2014 Nov; 11(6):1974-9. PubMed ID: 25433477
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.
Kehinde EO; Al-Mulla F; Kapila K; Anim JT
Scand J Urol Nephrol; 2011 Mar; 45(2):113-21. PubMed ID: 21091091
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization (FISH) to predict the efficacy of Bacillus Calmette-Guérin perfusion in bladder cancer.
Ke C; Liu Z; Zhu J; Zeng X; Hu Z; Yang C
Transl Cancer Res; 2022 Oct; 11(10):3448-3457. PubMed ID: 36388029
[TBL] [Abstract][Full Text] [Related]
8. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
9. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
[TBL] [Abstract][Full Text] [Related]
10. The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer.
Karnwal A; Venegas R; Shuch B; Bassett J; Rajfer J; Reznichek R
Can J Urol; 2010 Apr; 17(2):5077-81. PubMed ID: 20398445
[TBL] [Abstract][Full Text] [Related]
11. [Multiprobe FISH for enhanced prediction of recurrent bladder cancer].
Zellweger T; Benz G; Herzog M; Grilli B; Mihatsch MJ; Gasser TC; Bubendorf L
Verh Dtsch Ges Pathol; 2004; 88():194-8. PubMed ID: 16892552
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study.
Banek S; Schwentner C; Täger D; Pesch B; Nasterlack M; Leng G; Gawrych K; Bonberg N; Johnen G; Kluckert M; Gakis G; Todenhöfer T; Hennenlotter J; Brüning T; Stenzl A;
Urol Oncol; 2013 Nov; 31(8):1656-62. PubMed ID: 22621963
[TBL] [Abstract][Full Text] [Related]
13. Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.
Riesz P; Lotz G; Páska C; Szendrôi A; Majoros A; Németh Z; Törzsök P; Szarvas T; Kovalszky I; Schaff Z; Romics I; Kiss A
Pathol Oncol Res; 2007; 13(3):187-94. PubMed ID: 17922047
[TBL] [Abstract][Full Text] [Related]
14. Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer.
Zellweger T; Benz G; Cathomas G; Mihatsch MJ; Sulser T; Gasser TC; Bubendorf L
Int J Cancer; 2006 Oct; 119(7):1660-5. PubMed ID: 16646074
[TBL] [Abstract][Full Text] [Related]
15. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.
Yoder BJ; Skacel M; Hedgepeth R; Babineau D; Ulchaker JC; Liou LS; Brainard JA; Biscotti CV; Jones JS; Tubbs RR
Am J Clin Pathol; 2007 Feb; 127(2):295-301. PubMed ID: 17210520
[TBL] [Abstract][Full Text] [Related]
16. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
17. Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer.
Junker K; Fritsch T; Hartmann A; Schulze W; Schubert J
Cytogenet Genome Res; 2006; 114(3-4):279-83. PubMed ID: 16954667
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation.
Dimashkieh H; Wolff DJ; Smith TM; Houser PM; Nietert PJ; Yang J
Cancer Cytopathol; 2013 Oct; 121(10):591-7. PubMed ID: 23801650
[TBL] [Abstract][Full Text] [Related]
19. Is aneusomy of chromosome 9 alone a valid biomarker for urinary bladder cancer screening?
Panani AD; Kozirakis D; Anastasiou J; Babanaraki A; Malovrouvas D; Roussos C
Anticancer Res; 2006; 26(2A):1161-5. PubMed ID: 16619518
[TBL] [Abstract][Full Text] [Related]
20. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
